Old Web
English
Sign In
Acemap
>
authorDetail
>
Elizaveta Vasilenko
Elizaveta Vasilenko
Diabetes mellitus
Medicine
Physical therapy
Internal medicine
Tofacitinib
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AB0734 CHANGES IN HEIGHT AND BODY MASS INDEX OVER TIME IN PATIENTS WITH AXIAL SPONDYLOARTHITIS, TREATED WITH TUMOR NECROSIS FACTOR-A INHIBITORS
2019
Annals of the Rheumatic Diseases
Elizaveta Vasilenko
Olga Nikolaeva
Anna Dadalova
Ekaterina Gaydukova
Mazurov Vi
Inna Gaydukova
Show All
Source
Cite
Save
Citations (0)
THU0171 TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS – THE RESULTS OF RUSSIAN NATIONAL REGISTER OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
2019
Annals of the Rheumatic Diseases
Inna Gaydukova
V. Mazurov
Evgeniy Zhilyaev
Iuliia Grabovetskaya
Irina Marusenko
Elizaveta Vasilenko
D. Abdulganieva
Ilia Smitienko
A Misiyuk
Galina Lukina
Larisa Knyazeva
Elena Kalinina
Ruzana Samigullina
Irina Bondareva
Natalya Yudina
N. Lapkina
Nasonov El
Show All
Source
Cite
Save
Citations (0)
SAT0354 CARDIVASCULAR RISK IN YOUNG PATIENTS WITH LOW AXIAL SPONDYLOARTHRITIS ACTIVITY: PROMISING SCORING TOOLS
2019
Annals of the Rheumatic Diseases
Elizaveta Vasilenko
Olga Nikolaeva
Anna Dadalova
M. A. Korolev
V. Mazurov
Inna Gaydukova
Show All
Source
Cite
Save
Citations (0)
P3407Genetic predisposition and QRISK3 algorithm are promising cardiovascular risk scoring tools in young patients with axial spondyloarthritis (Bechterew's disease)
2019
European Heart Journal
Elizaveta Vasilenko
Anna Dadalova
Olga Nikolaeva
M. A. Korolev
Mazurov Vi
Inna Gaydukova
Show All
Source
Cite
Save
Citations (0)
1